Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. McGuff Pharmaceuticals, Inc.
FDA Inspection
•McGuff Pharmaceuticals, Inc.•March 31, 2017

McGuff Pharmaceuticals, Inc. – FDA Inspection, Mar 31, 2017

Record Details

This FDA Inspection record concerns McGuff Pharmaceuticals, Inc., with an inspection on March 31, 2017, issued by the Los Angeles District Office, covering human drugs.

Company
McGuff Pharmaceuticals, Inc.
Inspection Date
March 31, 2017
Product Type
Human Drugs
Office
Los Angeles District Office
People
  • Jennifer M. Gogley (FDA Associated Person)
  • Yasamin Ameri (FDA Associated Person)
  • Yvins Dezan
View Company Profile

ID · 5fff839d-7396-49b4-a06d-b1c8c086c1f0

Inspection Facts

Inspection number
1010923
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

15
  1. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  2. 21 CFR 211.100(b)SOPs not followed / documented
  3. 21 CFR 211.111Establishment of time limitations
  4. 21 CFR 211.113(b)Procedures for sterile drug products
  5. 21 CFR 211.122(e)Destruction of obsolete labeling
  6. 21 CFR 211.160(a)Lab controls established, including changes
  7. 21 CFR 211.160(b)(3)Drug products-sampling procedures/specifications
  8. 21 CFR 211.170(b)Annual visual exams of drug products
  9. 21 CFR 211.192Investigations of discrepancies, failures
  10. 21 CFR 211.194(a)(1)Sample identification and other information

Showing 10 of 15 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of McGuff Pharmaceuticals, Inc.

12
DateClassificationOfficeProject area
April 28, 2025OAILos Angeles District OfficeDrug Quality Assurance
August 20, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
January 26, 2024VAILos Angeles District OfficeNew Drug Evaluation
November 22, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 26, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 12 other inspections on the company page
Other documents for McGuff Pharmaceuticals, Inc.
  • FDA Inspection 1268175 - 2025-04-28
  • FDA Inspection 1229677 - 2024-08-20
  • FDA Inspection 1228033 - 2024-01-26
  • FDA Inspection 1110847 - 2019-11-22
  • FDA Inspection 1083919 - 2019-03-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore McGuff Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.